163 related articles for article (PubMed ID: 32766475)
1. Lack of Augmenter of Liver Regeneration Disrupts Cholesterol Homeostasis of Liver in Mice by Inhibiting the AMPK Pathway.
Wang X; Dong LY; Gai QJ; Ai WL; Wu Y; Xiao WC; Zhang J; An W
Hepatol Commun; 2020 Aug; 4(8):1149-1167. PubMed ID: 32766475
[TBL] [Abstract][Full Text] [Related]
2. Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.
Gandhi CR; Chaillet JR; Nalesnik MA; Kumar S; Dangi A; Demetris AJ; Ferrell R; Wu T; Divanovic S; Stankeiwicz T; Shaffer B; Stolz DB; Harvey SA; Wang J; Starzl TE
Gastroenterology; 2015 Feb; 148(2):379-391.e4. PubMed ID: 25448926
[TBL] [Abstract][Full Text] [Related]
3. Alleviation of Ischemia-Reperfusion Injury in Liver Steatosis by Augmenter of Liver Regeneration Is Attributed to Antioxidation and Preservation of Mitochondria.
Weng J; Li W; Jia X; An W
Transplantation; 2017 Oct; 101(10):2340-2348. PubMed ID: 28704337
[TBL] [Abstract][Full Text] [Related]
4. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
5. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
[TBL] [Abstract][Full Text] [Related]
6. Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression.
Kumar S; Rani R; Karns R; Gandhi CR
FASEB J; 2019 Mar; 33(3):3825-3840. PubMed ID: 30540918
[TBL] [Abstract][Full Text] [Related]
7. Metformin treatment prevents SREBP2-mediated cholesterol uptake and improves lipid homeostasis during oxidative stress-induced atherosclerosis.
Gopoju R; Panangipalli S; Kotamraju S
Free Radic Biol Med; 2018 Apr; 118():85-97. PubMed ID: 29499335
[TBL] [Abstract][Full Text] [Related]
8. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
9. Augmenter of liver regeneration ameliorates ischemia-reperfusion injury in steatotic liver via inhibition of the TLR4/NF-κB pathway.
Weng J; Wang X; Xu B; Li W
Exp Ther Med; 2021 Aug; 22(2):863. PubMed ID: 34178136
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice.
Kumar S; Wang J; Rani R; Gandhi CR
PLoS One; 2016; 11(1):e0147864. PubMed ID: 26808690
[TBL] [Abstract][Full Text] [Related]
11. Augmenter of liver regeneration: Essential for growth and beyond.
Ibrahim S; Weiss TS
Cytokine Growth Factor Rev; 2019 Feb; 45():65-80. PubMed ID: 30579845
[TBL] [Abstract][Full Text] [Related]
12. Hexacosanol reduces plasma and hepatic cholesterol by activation of AMP-activated protein kinase and suppression of sterol regulatory element-binding protein-2 in HepG2 and C57BL/6J mice.
Lee JH; Jia Y; Thach TT; Han Y; Kim B; Wu C; Kim Y; Seo WD; Lee SJ
Nutr Res; 2017 Jul; 43():89-99. PubMed ID: 28676202
[TBL] [Abstract][Full Text] [Related]
13. Augmenter of liver regeneration regulates autophagy in renal ischemia-reperfusion injury via the AMPK/mTOR pathway.
Pu T; Liao XH; Sun H; Guo H; Jiang X; Peng JB; Zhang L; Liu Q
Apoptosis; 2017 Jul; 22(7):955-969. PubMed ID: 28466106
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO
Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856
[TBL] [Abstract][Full Text] [Related]
15. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
[TBL] [Abstract][Full Text] [Related]
16. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
17. Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling.
Tang H; Yu R; Liu S; Huwatibieke B; Li Z; Zhang W
EBioMedicine; 2016 Apr; 6():139-148. PubMed ID: 27211556
[TBL] [Abstract][Full Text] [Related]
18. Deceleration of liver regeneration by knockdown of augmenter of liver regeneration gene is associated with impairment of mitochondrial DNA synthesis in mice.
Han LH; Dong LY; Yu H; Sun GY; Wu Y; Gao J; Thasler W; An W
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G112-22. PubMed ID: 25977511
[TBL] [Abstract][Full Text] [Related]
19. Augmenter of liver regeneration: Mitochondrial function and steatohepatitis.
Verma AK; Sharma A; Subramaniyam N; Gandhi CR
J Hepatol; 2022 Nov; 77(5):1410-1421. PubMed ID: 35777586
[TBL] [Abstract][Full Text] [Related]
20. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
